Skip to main content
. 2022 Dec 13;5:179. doi: 10.1038/s41746-022-00739-x

Table 4.

Clinical prescribing error rates by type and changes over study periods.

Error type Control—Paper (n = 9635 orders) Intervention—First 70 days of eMM (n = 16,734 orders) Intervention—One-year post-eMM (n = 8891 orders)
No. Errors Errors/100 orders (95% CI)a No. Errors Errors/100 orders (95% CI)a IRRb eMM vs Paper No. Errors Errors/100 orders (95% CI)a IRRb One-year post-eMM vs Paper
Wrong dose 644 6.68 (6.19–7.22) 1288 7.70 (7.29–8.13) 1.22 (1.04–1.43) 534 6.01 (5.52–6.54) 0.79 (0.68–0.93)
Overdose 308 3.20 (2.86–3.57) 674 4.03 (3.74–4.34) 1.22 (0.96–1.55) 247 2.78 (2.45–3.15) 0.79 (0.63–1.01)
Underdose 223 2.31 (2.03–2.64) 408 2.44 (2.21–2.69) 1.25 (0.95–1.66) 183 2.06 (1.78–2.38) 0.83 (0.64–1.07)
Wrong frequency 315 3.27 (2.93–3.65) 522 3.12 (2.86–3.40) 0.92 (0.73–1.16) 157 1.77 (1.51–2.06) 0.47 (0.36–0.61)
Wrong route 199 2.07 (1.80–2.37) 396 2.37 (2.14–2.61) 1.65 (1.20–2.27) 77 0.87 (0.69–1.08) 0.44 (0.27–0.71)
Duplicated drug therapy 140 1.45 (1.23–1.71) 457 2.73 (2.49–2.99) 1.82 (1.26–2.63) 205 2.31 (2.01–2.64) 1.48 (1.05–2.09)
Wrong drug 24 0.25 (0.17–0.37) 62 0.37 (0.29–0.48) 1.82 (0.66–5.00) 15 0.17 (0.10–0.28) 0.49 (0.11–2.23)
Drug–drug interaction 20 0.21 (0.13–0.32) 71 0.42 (0.34–0.54) 0.69 (0.23–2.09) 17 0.19 (0.12–0.31) 0.39 (0.09–1.73)
Allergy 20 0.21 (0.13–0.32) 19 0.11 (0.07–0.18) 0.45 (0.12–1.75) 13 0.15 (0.08–0.25) 3.17 (0.48–20.9)
Inadequate monitoring 19 0.20 (0.13–0.31) 40 0.24 (0.18–0.33) 1.19 (0.34–4.19) 5 0.06 (0.02–0.14)

– indicates too few errors for modelling (Supplementary Table 3 reports remaining error categories).

aCrude error rates and 95% CIs are from simple Poisson models.

bAdjusted incidence rate ratio (IRR) and 95% CIs are from generalised linear mixed models adjusting for study time (immediate post-eMM model only), patient age, and clustering by ward and patient.